NCT06824662
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06824662
Title Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nader Sanai
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.